Clinical observation of improved transvaginal pelvic organ prolapse surgery
改良经阴道盆腔器官脱垂手术的临床疗效观察

摘要

目的 分析盆腔器官脱垂患者临床治疗时使用改良经阴道盆腔器官脱垂手术的效果。方法 我院2023年1月至12月期间收治的40例盆腔器官脱垂患者设为观察组，并回顾2021至2022年间接受阴式全子宫切除及阴道壁修补术的患者作为对照组进行对比分析，对比两组临床疗效。结果 两组平均住院日、治疗费用和术后阴道长度差异均无统计学意义（P＞0.05）。但观察组手术时间短于对照组，术中出血量和术后3个月、6个月及12个月的总复发率低于对照组，差异均存在统计学意义（P＜0.05）。结论 改良经阴道盆腔器官脱垂手术具有较好疗效，能够优化患者临床指标，改善预后，减少术后复发，具有较好应用效果。

Abstract

Objective To analyze the effect of modified transvaginal pelvic organ prolapse surgery in the clinical treatment of patients with pelvic organ prolapse.
Methods A total of 40 patients with pelvic organ prolapse admitted to our hospital from January to December 2023 were set as the observation group, and patients who underwent vaginal hysterectomy and vaginal wall repair from 2021 to 2022 were retrospectively analyzed as the control group to compare the clinical efficacy of the two groups.
Results There was no statistically significant difference in the average length of hospital stay, treatment costs, and postoperative vaginal length between the two groups (P>0.05). However, the operation time of the observation group was shorter than that of the control group, and the intraoperative blood loss and the total recurrence rate at 3 months, 6 months, and 12 months after surgery were lower than those of the control group, and the differences were statistically significant (P<0.05).
Conclusion   The modified transvaginal pelvic organ prolapse surgery has a good effect, can optimize the clinical indicators of patients, improve prognosis, reduce postoperative recurrence, and has a good application effect.